Background Acne vulgaris is a common skin problem that may result in significant scarring
and systemic comorbidities. Adverse effects and increasing resistance to available …

Introduction There is limited basic research on carbon dioxide (CO2) fractional laser,
indicating blind spots in CO2 fractional laser treatment of certain diseases. This study aimed …

Alopecia areata (AA) is a disease that affects the psychological well‐being of the affected
individuals. Laser‐assisted drug delivery and microneedling (MN) are promising methods …

Background Transepidermal drug delivery is a novel therapeutic technique to boost efficacy
of topical drugs. Aim In this clinical trial we evaluate the efficacy of the combination of …

Objectives Hair loss, including alopecia, is a common dermatological issue worldwide. At
present, the application of fractional carbon dioxide (CO2) laser in the treatment of alopecia …

AA is a common autoimmune skin disease that causes hair loss on the scalp and sometimes
other areas of the body. New therapy approaches for alopecia areata are emerging, with the …

Alopecia areata (AA) is a common cause of hair loss with no available universally successful
treatment. Thus, new innovative treatments are urgently needed. This research aimed to …

Background Corticosteroids have been the mainstay of treatment for alopecia areata (AA).
Recently, the 308‐nm excimer laser has been proposed for treating AA. Objectives To …

Background: Alopecia areata is an autoimmune disorder of patchy non scarring hair loss.
Steroids, either Intralesional, eg, triamcinolone or potent topical, eg, clobetasol are the first …

Alopecia areata (AA) is a non-scarring autoimmune disease requiring long-term treatments.
Topical, intralesional or systemic corticosteroids are the first option. However, considering …